| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $28.2M | $386.0K | $928.0K |
| YoY Revenue Growth % | +7193.0% | -58.4% | — |
| Gross Profit | -$716.0K | $37.0K | — |
| Gross Margin % | -2.5% | 9.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$45.1M | -$1.8M | -$531.0K |
| Operating Margin % | -80.0% | -80.0% | -57.2% |
| Net Income (GAAP) | -$28.1M | -$13.7M | -$574.0K |
| EBITDA (Normalized) | — | $17.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $7.1M | $22.7M | -$1.8M |
| Capital Expenditures (CapEx) | — | $24.3M | — |
| Free Cash Flow (FCF) | $7.1M | -$1.6M | -$1.8M |
| FCF Margin % | 25.1% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -11.5% | -12.7% | — |
| Cash & Short-Term Equivalents | $999.0K | $2.0K | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $311.6M | $10.9M | — |